1. Home
  2. INLX vs ACRV Comparison

INLX vs ACRV Comparison

Compare INLX & ACRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INLX
  • ACRV
  • Stock Information
  • Founded
  • INLX 1996
  • ACRV 2018
  • Country
  • INLX United States
  • ACRV United States
  • Employees
  • INLX N/A
  • ACRV N/A
  • Industry
  • INLX EDP Services
  • ACRV Medicinal Chemicals and Botanical Products
  • Sector
  • INLX Technology
  • ACRV Health Care
  • Exchange
  • INLX Nasdaq
  • ACRV Nasdaq
  • Market Cap
  • INLX 60.5M
  • ACRV 59.9M
  • IPO Year
  • INLX N/A
  • ACRV 2022
  • Fundamental
  • Price
  • INLX $14.47
  • ACRV $1.18
  • Analyst Decision
  • INLX
  • ACRV Strong Buy
  • Analyst Count
  • INLX 0
  • ACRV 5
  • Target Price
  • INLX N/A
  • ACRV $19.75
  • AVG Volume (30 Days)
  • INLX 3.5K
  • ACRV 1.3M
  • Earning Date
  • INLX 05-16-2025
  • ACRV 05-13-2025
  • Dividend Yield
  • INLX N/A
  • ACRV N/A
  • EPS Growth
  • INLX N/A
  • ACRV N/A
  • EPS
  • INLX N/A
  • ACRV N/A
  • Revenue
  • INLX $18,018,373.00
  • ACRV N/A
  • Revenue This Year
  • INLX $7.58
  • ACRV N/A
  • Revenue Next Year
  • INLX N/A
  • ACRV N/A
  • P/E Ratio
  • INLX N/A
  • ACRV N/A
  • Revenue Growth
  • INLX 6.70
  • ACRV N/A
  • 52 Week Low
  • INLX $5.85
  • ACRV $1.30
  • 52 Week High
  • INLX $16.50
  • ACRV $10.29
  • Technical
  • Relative Strength Index (RSI)
  • INLX 55.56
  • ACRV 29.23
  • Support Level
  • INLX $12.00
  • ACRV $1.32
  • Resistance Level
  • INLX $14.99
  • ACRV $1.50
  • Average True Range (ATR)
  • INLX 0.67
  • ACRV 0.19
  • MACD
  • INLX -0.09
  • ACRV 0.06
  • Stochastic Oscillator
  • INLX 66.40
  • ACRV 2.08

About INLX Intellinetics Inc.

Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Document Management and Document Conversion. The Document Management segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Conversion offerings aid clients as a part of their overall document to convert documents from one medium to another. Majority of revenue is from Document Conversion Segment.

About ACRV Acrivon Therapeutics Inc.

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.

Share on Social Networks: